Products

Catalog No	Chemical Name	CAS Number	Purity
25196	Rosolutamide ( AJ-201 ; ASC-JM17 )	1039760-91-2 , 2074613-88-8 [ALTERNATIVE]	≧98.0%
Rosolutamide (formerly known as AJ-201, ASC-JM-17 or ALZ-002) is a nuclear factor ery
25150	Ranosidenib	2301974-60-5	≧98.0%
Ranosidenib, also known as HMPL-306, is an isocitrate dehydrogenase (IDH) inhibitor.
25140	Revumenib	2169919-21-3	98% Min.
Revumenib, also known as SNDX-5613, is a potent and specific Menin-MLL inhibitor. It
25125	Radiprodil	496054-87-6	98% Min.
Radiprodil, also known as RGH-896, is an orally active and selective NMDA receptors a
25124	Radiprodil	496054-87-6	98% Min.
Radiprodil, also known as RGH-896, is an orally active and selective NMDA receptors a
25106	Rilzabrutinib	1575596-29-0	98% Min.
Rilzabrutinib, also known as PRN1008, is a reversible covalent, selective and oral ac
25100	Rimiducid	195514-63-7	98% Min.
Rimiducid, also known as AP1903, is a lipid-permeable bivalent "dimerizer"
25091	Rilzabrutinib ( PRN1008 )	1575591-66-0	≧98.0%
Rilzabrutinib ( PRN1008 ) is an oral, reversible, covalent, small-molecule inhibitor
25084	Ronopterin	206885-38-3	98% Min.
Ronopterin is a potent Nitric oxide synthase inhibitor and Neuroprotectant.
25074	RMC-6236	2765081-21-6	98% Min.
Daraxonrasib, also known as RMC-6236 and RAS-IN-2, is a potent and selective RAS(ON)
25068	Roginolisib	1305267-37-1	98% Min.
Roginolisib, also known as MSC2360844 and IOA-244, is a potent, orally active and sel
25050	Reparixin	266359-83-5	98% Min.
Reparixin is an inhibitor of CXCR2 function, which attenuates inflammatory responses
25038	(R)-2-(3,5-difluorophenyl)-2-hydroxyacetic acid	794566-88-4	98% Min.

25035	Relacorilant	1496510-51-0	98% Min.
Relacorilant is discontinued.
24148	RGT-018	2794934-49-7	98% Min.
RGT-018 is a potent and orally active SOS1 inhibitor with anti-tumor effects.
24136	(Rac)-SHIN2	2204289-53-0	98% Min.
(Rac)-SHIN2 is a serine hydroxymethyltransferase (SHMT) inhibitor having 1,4-dihydrop
24130	(R)-(-)-α-Methylhistamine HBr	868698-49-1	98% Min.
(R)-(-)-α-Methylhistamine dihydrobromide is a very potent, high affinity H3 agonist
24078	Risovalisib mesylate	1494684-33-1	98% Min.
CYH33 (CYH-33) is a novel potent, PI3Kα-selective inhibitor with IC50 of 5.9 nM/598
20666	RMC-4998	2642037-07-6	98% Min.
RMC-4998 is a tri-complex inhibitor and KRASG12C inhibitor. RMC-4998 targets the acti
24008	RNK-05047	2503036-46-0	≧98.0%
RNK-05047 is a PROTAC degrader of BRD4 which displays significant tumor growth inhibi
20655	(R)-Praziquantel	57452-98-9	98% Min.
(R)-Praziquantel is an active enantiomer of praziquantel that acts as a potent anthel
20652	Resminostat	864814-88-0	98% Min.
Resminostat, also known as 4S-201 and RAS2410, is an orally bioavailable inhibitor of
20627	Resigratinib	2750709-91-0	98% Min.
Resigratinib is a fibroblast growth factor receptor tyrosine kinase inhibitor and ant
20621	Risvodetinib	2031185-00-7	98% Min.
Risvodetinib, also known as IkT-148009., is a brain-penetrant c-Abl inhibitor with a
20595	Ropidoxuridine	93265-81-7	98% Min.
Ropidoxuridine is a novel, orally available, thymidine analogue and prodrug for IUdR,
20526	RPT193	2366152-15-8	98% Min.

230403	(R,S)-BI 1015550	1423719-27-0	≧98.0%
BI 1015550 is a novel PDE4 inhibitor showing a preferential enzymatic inhibition of P
233901	RRX-001	925206-65-1	≧98.0%
RRx-001 is a highly selective NLRP3 inhibitor with vascular normalization and tumor a
20460	Ro5-3335	30195-30-3	≧98.0%
Ro5-3335 is a lipophilic small molecule RUNX1 inhibitor.
20452	Ritlecitinib tosylate	2192215-81-7	98% Min.
Ritlecitinib, also known as PF-06651600, is a potent and selective JAK3 inhibitor. PF